Karachi, Sanofi Aventis Pakistan Limited, a prominent pharmaceutical company, has announced an Extraordinary General Meeting (EoGM) scheduled for Tuesday, September 5, 2023, at 10:30 a.m. The purpose of the meeting is to discuss and finalize crucial matters pertaining to the company's future.

The Securities and Exchange Commission of Pakistan (SECP) has issued circulars mandating virtual general meetings for listed companies in addition to physical meetings. Complying with this directive, Sanofi Aventis Pakistan Limited has made necessary arrangements to conduct the meeting both in-person and virtually. The in-person meeting will take place at the prestigious Auditorium of the Institute of Chartered Accountants of Pakistan (ICAP), situated on Chartered Accountants Avenue, Block 8 Clifton, Karachi.

With strict adherence to quorum provisions and regulatory requirements, the Company aims to ensure the transparency and integrity of the decision-making process during the EoGM.

The central agenda of the EoGM includes the confirmation of the minutes of the 55th Annual General Meeting held on May 25, 2023. Additionally, a significant proposal is on the table for consideration:

"RESOLVED THAT the name of the Company be changed from 'Sanofi-Aventis Pakistan Limited' to 'Hoechst Pakistan Limited'."

This proposition marks a potential transformation for the pharmaceutical giant, signifying not only a shift in identity but also potentially strategic realignments within the company. This name change resolution reflects the company's adaptability and its commitment to staying in line with the evolving dynamics of the industry.

As part of the procedural framework, the share transfer books of Sanofi Aventis Pakistan Limited will remain closed from August 29, 2023, to September 05, 2023, inclusively. This measure is implemented to facilitate the seamless transition in the event of a name change and to ensure accuracy in the company's records.

The EoGM presents a pivotal moment in the history of the company, with its potential to reshape its branding and future endeavors. The leadership of Sanofi Aventis Pakistan Limited is dedicated to fulfilling its obligations to stakeholders and complying with regulatory mandates as it embarks on this significant journey of change and renewal.